Philip Pisa is a highly accomplished individual with a rich background in the pharmaceutical industry and entrepreneurship. He has held various roles at Roche, a global leader in the pharma sector, including Director of Digital, Marketing, and Innovation. Philip is passionate about making science, technology, and knowledge accessible to all, with the ultimate goal of helping people live longer, healthier, and happier lives.

Philip's educational foundation is strong, as he pursued an MA Hons in Economics from The University of Edinburgh, an MSc in Economics & Finance from the Barcelona Graduate School of Economics, and a BA in Economics & Finance from The University of Hong Kong. He then continued to enhance his knowledge through the Singularity University's Exponential Foundation series and completed a Nanodegree in Machine Learning Engineer from Udacity.

Throughout his career, Philip has demonstrated his ability to excel in diverse roles within the pharmaceutical industry. He founded Yumee, a startup aimed at harnessing the power of science and technology to improve health outcomes. He has also showcased his leadership skills as the Digital Go To Market leader at Roche, responsible for driving digital transformation initiatives. Additionally, Philip has gained valuable expertise in global portfolio strategy, business planning, audit management, finance, and controlling, making him a well-rounded professional.

Philip's extensive experience includes key positions within Roche, such as Global Business Plan Lead, R&D Audit Manager, Head of Controlling for Diagnostics, and Pharma Controller. He has also contributed to important initiatives outside of Roche, including the CHOosing Interventions that are Cost Effective (CHOICE) initiative for the World Health Organization and working in the International Health Economic and Pricing Strategy department for Avastin.

With his in-depth experience and knowledge, Philip brings unique insights to the table, allowing him to effectively navigate the complexities of the pharmaceutical industry. His expertise lies in digital transformation, innovation, portfolio strategy, business planning, finance, and health economics. Philip's drive to benefit society and his dedication to leveraging science and technology make him a remarkable professional who strives for positive change in the healthcare ecosystem.